Drug–drug synthetic lethality to combat cancer: From bench to bedside
Main Authors: | Yu Chen, Wu Yang, Jiaojiao Zheng, René Bernards, Haojie Jin |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-05-01
|
Series: | Clinical and Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/ctm2.1269 |
Similar Items
-
HER3 in cancer: from the bench to the bedside
by: Lucía Gandullo-Sánchez, et al.
Published: (2022-10-01) -
Targeting KRAS in Colorectal Cancer: A Bench to Bedside Review
by: Fernand Bteich, et al.
Published: (2023-07-01) -
The Role of Autophagy in Pancreatic Cancer: From Bench to the Dark Bedside
by: Kıvanç Görgülü, et al.
Published: (2020-04-01) -
Metformin and Cancer Glucose Metabolism: At the Bench or at the Bedside?
by: Cecilia Marini, et al.
Published: (2021-08-01) -
From bench to bedside: ways and steps of drug discovery
by: Ş.Ş. Alkan
Published: (2011-12-01)